• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可视吸收光谱学作为一种生物标志物,可预测手术切除食管癌的治疗反应和预后。

Visible-absorption spectroscopy as a biomarker to predict treatment response and prognosis of surgically resected esophageal cancer.

机构信息

Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Department of Physics and Center for Biomedical Technology, Chung Yuan Christian University, Taoyuan, Taiwan.

出版信息

Sci Rep. 2016 Sep 14;6:33414. doi: 10.1038/srep33414.

DOI:10.1038/srep33414
PMID:27624872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5022060/
Abstract

The application of optical absorption spectra in prognostic prediction has hardly been investigated. We developed and evaluated a novel two dimensional absorption spectrum measurement system (TDAS) for use in early diagnosis, evaluating response to chemoradiation, and making prognostic prediction. The absorption spectra of 120 sets of normal and tumor tissues from esophageal cancer patients were analyzed with TDAS ex-vivo. We demonstrated the cancerous tissue, the tissue from patients with a poor concurrent chemoradiotherapy (CCRT) response, and the tissue from patients with an early disease progression each had a readily identifiable common spectral signature. Principal component analysis (PCA) classified tissue spectra into distinct groups, demonstrating the feasibility of using absorption spectra in differentiating normal and tumor tissues, and in predicting CCRT response, poor survival and tumor recurrence (efficiencies of 75%, 100% and 85.7% respectively). Multivariate analysis revealed that patients identified as having poor-response, poor-survival and recurrence spectral signatures were correlated with increased risk of poor response to CCRT (P = 0.012), increased risk of death (P = 0.111) and increased risk of recurrence (P = 0.030) respectively. Our findings suggest that optical absorption microscopy has great potential to be a useful tool for pre-operative diagnosis and prognostic prediction of esophageal cancer.

摘要

光学吸收光谱在预后预测中的应用几乎未被研究过。我们开发并评估了一种新型的二维吸收光谱测量系统(TDAS),用于早期诊断、评估放化疗反应和进行预后预测。我们用 TDAS 对 120 组食管癌患者的正常和肿瘤组织的吸收光谱进行了分析。我们发现,癌症组织、对同期放化疗反应差的患者组织和疾病早期进展的患者组织都具有可识别的共同光谱特征。主成分分析(PCA)将组织光谱分为不同的组,证明了吸收光谱在区分正常和肿瘤组织以及预测放化疗反应、不良生存和肿瘤复发方面的可行性(效率分别为 75%、100%和 85.7%)。多变量分析表明,被鉴定为具有不良反应、不良生存和复发光谱特征的患者与对放化疗反应不良的风险增加(P=0.012)、死亡风险增加(P=0.111)和复发风险增加(P=0.030)相关。我们的研究结果表明,光学吸收显微镜具有成为食管癌术前诊断和预后预测的有用工具的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/1956dea83199/srep33414-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/f9a450d5ade3/srep33414-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/6c7757fa3f91/srep33414-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/2dd8ce0d80a3/srep33414-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/7182f1bab7a2/srep33414-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/1956dea83199/srep33414-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/f9a450d5ade3/srep33414-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/6c7757fa3f91/srep33414-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/2dd8ce0d80a3/srep33414-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/7182f1bab7a2/srep33414-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af8d/5022060/1956dea83199/srep33414-f5.jpg

相似文献

1
Visible-absorption spectroscopy as a biomarker to predict treatment response and prognosis of surgically resected esophageal cancer.可视吸收光谱学作为一种生物标志物,可预测手术切除食管癌的治疗反应和预后。
Sci Rep. 2016 Sep 14;6:33414. doi: 10.1038/srep33414.
2
HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.肿瘤上皮细胞中HLA - DR的表达是食管腺癌患者的独立预后指标。
Cancer Immunol Immunother. 2017 Jul;66(7):841-850. doi: 10.1007/s00262-017-1983-1. Epub 2017 Mar 18.
3
Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.食管腺癌中Smad4缺失与疾病复发倾向增加及生存率低相关。
Am J Surg Pathol. 2015 Apr;39(4):487-95. doi: 10.1097/PAS.0000000000000356.
4
Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.原发性食管癌根治性治疗后局部区域复发的确定性放化疗。
Dis Esophagus. 2017 Feb 1;30(2):1-5. doi: 10.1111/dote.12539.
5
Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation.经微探头超声评估的肿瘤长度可预测接受同步放化疗的伴有狭窄的晚期食管鳞癌患者的生存情况。
Dis Esophagus. 2011 Nov;24(8):590-5. doi: 10.1111/j.1442-2050.2011.01195.x. Epub 2011 May 3.
6
High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.Y 盒结合蛋白-1 高表达与可切除食管鳞癌患者的不良预后相关。
Ann Surg Oncol. 2011 Nov;18(12):3370-6. doi: 10.1245/s10434-011-1725-0. Epub 2011 Jun 1.
7
Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.Copine5 表达预测食管鳞癌根治性切除术后的预后。
Oncol Rep. 2018 Dec;40(6):3772-3780. doi: 10.3892/or.2018.6742. Epub 2018 Sep 27.
8
Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.预测 pT1N0 食管鳞癌复发的临床病理参数。
World J Gastroenterol. 2018 Dec 7;24(45):5154-5166. doi: 10.3748/wjg.v24.i45.5154.
9
Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.新辅助放化疗后IgG4 +浆细胞浸润对食管腺癌的预后意义。
Hum Pathol. 2017 Aug;66:126-135. doi: 10.1016/j.humpath.2017.06.009. Epub 2017 Jun 28.
10
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.脂质生物合成相关标志物HSD17B2和HMGCS2在新辅助同步放化疗治疗的直肠癌中的预后影响。
Tumour Biol. 2015 Sep;36(10):7675-83. doi: 10.1007/s13277-015-3503-2. Epub 2015 May 1.

引用本文的文献

1
Hydrogel gratings with patterned analyte responsive dyes for spectroscopic sensing.用于光谱传感的带有图案化分析物响应染料的水凝胶光栅。
RSC Adv. 2021 Dec 17;11(63):40197-40204. doi: 10.1039/d1ra08610c. eCollection 2021 Dec 13.
2
Spectroscopy for Esophageal Diseases.用于食管疾病的光谱学
Gastroenterol Hepatol (N Y). 2018 Dec;14(12):722-724.
3
Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma.自噬相关基因5(ATG5)的基因多态性可预测早期食管鳞状细胞癌患者的生存和复发情况。

本文引用的文献

1
Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.裸鼠体内人乳腺癌异种移植瘤及乳腺活检组织的光谱分析
Front Biosci. 1998 Jan 1;3:a1-10. doi: 10.2741/a244.
2
Recurrence prediction in oral cancers: a serum Raman spectroscopy study.口腔癌复发预测:一项血清拉曼光谱研究。
Analyst. 2015 Apr 7;140(7):2294-301. doi: 10.1039/c4an01860e.
3
Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma.食管鳞癌完全切除术后复发患者的预后因素。
Oncotarget. 2017 Sep 8;8(53):91494-91504. doi: 10.18632/oncotarget.20793. eCollection 2017 Oct 31.
J Thorac Dis. 2014 Jul;6(7):949-57. doi: 10.3978/j.issn.2072-1439.2014.07.14.
4
Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.EGF 和 VEGF 的遗传变异可预测晚期食管鳞癌患者的预后。
PLoS One. 2014 Jun 19;9(6):e100326. doi: 10.1371/journal.pone.0100326. eCollection 2014.
5
Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.治疗前活检的基因表达分析可预测食管鳞癌对新辅助放化疗的病理反应。
Ann Oncol. 2014 Sep;25(9):1769-1774. doi: 10.1093/annonc/mdu201. Epub 2014 Jun 6.
6
Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.缺氧调节基因表达与局部胃食管交界癌预后的关系。
Acta Oncol. 2013 Oct;52(7):1327-35. doi: 10.3109/0284186X.2013.818247. Epub 2013 Aug 19.
7
The survival impact of XPA and XPC genetic polymorphisms on patients with esophageal squamous cell carcinoma.XPA 和 XPC 基因多态性对食管鳞癌患者生存的影响。
Ann Surg Oncol. 2013 Feb;20(2):562-71. doi: 10.1245/s10434-012-2622-x. Epub 2012 Sep 1.
8
Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1α-mediated mRNA transcription and continuous protein synthesis.缺氧通过 HIF-1α 介导的 mRNA 转录和持续的蛋白质合成诱导食管鳞癌细胞 IGFBP3 的产生。
FASEB J. 2012 Jun;26(6):2620-30. doi: 10.1096/fj.11-198598. Epub 2012 Mar 13.
9
Some observations on the absorption spectra of various myoglobin derivatives found in meat.关于肉类中发现的各种肌红蛋白衍生物吸收光谱的一些观察结果。
Meat Sci. 1996 Mar;42(3):277-88. doi: 10.1016/0309-1740(94)00045-x.
10
Genetic variants in DNA repair predicts the survival of patients with esophageal cancer.DNA 修复中的遗传变异可预测食管癌患者的生存情况。
Ann Surg. 2011 May;253(5):918-27. doi: 10.1097/SLA.0b013e318216f374.